Cargando…
Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study
The past two decades of research have raised gut microbiota composition as a contributing factor to the development of obesity, and higher abundance of certain bacterial species has been linked to the lean phenotype, such as Akkermansia muciniphila. The ability of pre- and probiotics to affect metab...
Autores principales: | Yde, Christian Clement, Jensen, Henrik Max, Christensen, Niels, Servant, Florence, Lelouvier, Benjamin, Lahtinen, Sampo, Stenman, Lotta K., Airaksinen, Kaisa, Kailanto, Henna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638982/ https://www.ncbi.nlm.nih.gov/pubmed/34855861 http://dx.doi.org/10.1371/journal.pone.0260765 |
Ejemplares similares
-
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats
por: Lyra, Anna, et al.
Publicado: (2012) -
Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice
por: Stenman, Lotta K., et al.
Publicado: (2015) -
Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
por: Uusitupa, Henna-Maria, et al.
Publicado: (2020) -
Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells
por: Zhang, Hongxia, et al.
Publicado: (2020) -
Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti‐inflammatory drug: A randomized, placebo‐controlled, double‐blind clinical trial
por: Mäkelä, Sanna M., et al.
Publicado: (2021)